Dear ASPS community. Many of our patients who participated in Cediranib clinical trials reported on our […]
Please note the two Phase II clinical trials available for ASPS patients in the US: […]
Dear ASPS Community, We are very happy to report the opening of another clinical trial for […]
Scientists from the group of Dr. Massimo Loda reported the results of an extensive study that […]
Cediranib (Recentin, AZD2171) is an inhibitor of VEGF (Vascular Endothelial Growth Factor) receptors. Therefore, the drug […]
The GVAX cancer vaccine clinical trial, which has been opened in January 2006 is no more […]
ArQule Achieves Clinical Milestone in MiT Trial with ARQ 197 Thursday October 2, 8:01 am ET […]
Previously, we reported that Alveolar Soft Part Sarcoma is a candidate for therapy by drugs that […]
Update on the ARQ 197 Clinical Trial (November 23): The new clinical trial (read below) is […]
Dear ASPS community. As you probably know, the GVAX cancer vaccine clinical trial has been open […]
Read, write, learn, stay connected!
PMC Team ASPS
Please help find a cure for ASPS - donate your tumor!